Rep. Gilbert Ray Cisneros, Jr. Sells Shares of ITT Inc. (NYSE:ITT)

Key Points

• Rep. Gilbert Ray Cisneros Jr. sold between $15,001 and $50,000 of ITT shares on September 21, with the transaction disclosed October 12. He also reported another ITT sale in the same value range on September 29.
• ITT reported quarterly EPS of $2.08, beating estimates of $1.92, while revenue rose 51.5% year over year to $1.47 billion. The company issued FY 2026 EPS guidance of $8.12–$8.32 and pays a quarterly dividend of $0.386 per share.
• Wall Street remains positive, with eight analysts rating ITT a Buy and one assigning a Hold; the stock has a “Moderate Buy” consensus and an average price target of $259.56, versus an opening price of $201.54.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of ITT Inc. (NYSE:ITT). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $15,001 and $50,000 in ITT stock on September 21st. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Benchmark Electronics NYSE: BHE on 10/1/2026.
• Sold $1,001 - $15,000 in shares of Oxford Industries NYSE: OXM on 9/29/2026.
• Sold $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/29/2026.
• Sold $15,001 - $50,000 in shares of ITT NYSE: ITT on 9/29/2026.
• Sold $1,001 - $15,000 in shares of BridgeBio Pharma NASDAQ: BBIO on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Tandem Diabetes Care NASDAQ: TNDM on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Cytokinetics NASDAQ: CYTK on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Ultragenyx Pharmaceutical NASDAQ: RARE on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of YETI NYSE: YETI on 9/29/2026.
• Sold $1,001 - $15,000 in shares of AtriCure NASDAQ: ATRC on 9/29/2026.

ITT Stock Performance

Shares of ITT stock opened at $201.54 on Wednesday. ITT Inc. has a 52-week low of $166.96 and a 52-week high of $230.32. The company has a quick ratio of 0.85, a current ratio of 1.26 and a debt-to-equity ratio of 0.60. The stock has a market cap of $18.02 billion, a PE ratio of 39.52, a price-to-earnings-growth ratio of 1.65 and a beta of 1.25. The business has a 50-day simple moving average of $206.12 and a 200-day simple moving average of $201.29.

ITT (NYSE:ITT - Get Free Report) last posted its earnings results on Thursday, August 6th. The conglomerate reported $2.08 EPS for the quarter, topping the consensus estimate of $1.92 by $0.16. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.39 billion. ITT had a return on equity of 15.90% and a net margin of 8.90%. ITT's revenue for the quarter was up 51.5% compared to the same quarter last year. During the same period last year, the company earned $1.64 earnings per share. ITT has set its FY 2026 guidance at 8.120-8.320 EPS. On average, equities analysts expect that ITT Inc. will post 8.25 EPS for the current year.

ITT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, October 5th. Stockholders of record on Tuesday, September 8th were issued a $0.3860 dividend. This represents a $1.54 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, September 8th. ITT's payout ratio is 30.20%.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Stifel Nicolaus raised their price target on shares of ITT from $246.00 to $250.00 and gave the company a "buy" rating in a research report on Monday, July 20th. KeyCorp raised their price objective on ITT from $250.00 to $263.00 and gave the company an "overweight" rating in a report on Friday, August 7th. DA Davidson raised their price objective on ITT from $255.00 to $265.00 and gave the company a "buy" rating in a report on Tuesday, August 11th. Weiss Ratings raised shares of ITT from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, October 8th. Finally, BMO Capital Markets reaffirmed an "outperform" rating and set a $273.00 target price on shares of ITT in a report on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, ITT has a consensus rating of "Moderate Buy" and an average target price of $259.56.

Institutional Trading of ITT

Large investors have recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in ITT during the second quarter worth about $28,000. Bayban acquired a new position in ITT in the 4th quarter valued at about $31,000. Trust Co. of Vermont purchased a new stake in shares of ITT in the 2nd quarter valued at approximately $33,000. Ascentis Independent Advisors purchased a new stake in shares of ITT in the 1st quarter valued at approximately $42,000. Finally, Transamerica Financial Advisors LLC purchased a new stake in shares of ITT in the 2nd quarter valued at approximately $43,000. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Luca Savi acquired 5,019 shares of ITT stock in a transaction that occurred on Monday, August 31st. The shares were purchased at an average cost of $199.56 per share, for a total transaction of $1,001,591.64. Following the acquisition, the chief executive officer owned 267,373 shares in the company, valued at approximately $53,356,955.88. This represents a 1.91% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Graziano De sold 700 shares of the company's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $214.54, for a total transaction of $150,178.00. Following the completion of the transaction, the chief accounting officer directly owned 7,159 shares in the company, valued at $1,535,891.86. The trade was a 8.91% decrease in their position. The SEC filing for this sale provides additional information. 0.88% of the stock is owned by company insiders.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

ITT Company Profile

ITT Inc NYSE: ITT is a global manufacturer of highly engineered components and technologies serving the transportation, energy, industrial, infrastructure, and aerospace and defense markets. The company develops products designed to support critical applications where reliability, performance, and safety are essential.

ITT operates through three principal business segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. Its products include brake pads and friction materials, shock absorbers, pumps, valves, monitoring and control systems, connectors, switches, and other specialized components.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.